Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Workplace Wellness: Improving Your Experience at Work

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04082624
Recruitment Status : Completed
First Posted : September 9, 2019
Last Update Posted : September 9, 2019
Sponsor:
Collaborator:
Social Sciences and Humanities Research Council of Canada
Information provided by (Responsible Party):
Ryan Rhodes, University of Victoria

Brief Summary:

The primary objective of study was to compare affective (i.e., highlighted emotional benefits), instrumental (i.e., highlighted other health benefits), and self-regulation (i.e., demonstrated ways to plan, set goals, etc.) interventions in terms of their ability to motivate less sitting in the workplace. Research of this type is important because people sit for long periods of time at work which adversely affects their health and productivity.

It was hypothesized that the affective and self-regulation groups would sit less than the instrumental and control groups based on evidence indicating that affective attitude (i.e., emotional evaluation of the behavior) and self-regulation techniques tend to predict behavior.


Condition or disease Intervention/treatment Phase
Sedentary Behavior Obesity Behavioral: Nutrition condition Behavioral: Affective condition Behavioral: Instrumental condition Behavioral: Self-regulation condition Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 116 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Workplace Wellness: Improving Your Experience at Work
Actual Study Start Date : September 2014
Actual Primary Completion Date : April 2015
Actual Study Completion Date : April 2015

Arm Intervention/treatment
Active Comparator: Nutrition condition
Received nutrition information such as the comparison of nutritional information between orange juice and soda pop. Received intervention following measurements at baseline, week 4, and week 8.
Behavioral: Nutrition condition
Received nutritional information in in-person PowerPoint presentations.

Experimental: Affective condition
Learned about the affective benefits (e.g., less depression) of reduced office sitting time through taking active breaks. Received intervention following measurements at baseline, week 4, and week 8.
Behavioral: Affective condition
Received information about affective benefits of less sitting in the workplace in in-person PowerPoint presentations.

Experimental: Instrumental condition
Learned about instrumental benefits such as the relationship between sitting and cardiovascular disease and absenteeism at work. Received intervention following measurements at baseline, week 4, and week 8.
Behavioral: Instrumental condition
Received information about instrumental benefits of less sitting in the workplace in in-person PowerPoint presentations.

Experimental: Self-regulation condition
Learned how to self-monitor their sedentary behavior and active breaks. They also learned how to create prompts/cues (e.g., sticky note reminder), problem solve to overcome barriers, action plan (i.e., specifying when, where, and how to do the behavior), and set goals in order to be less sedentary according to SMART (i.e., specific, measurable, attainable, relevant, time-oriented) principles. Received intervention following measurements at baseline, week 4, and week 8.
Behavioral: Self-regulation condition
Learned how to self-regulate behavior to sit less in the workplace in in-person PowerPoint presentations.




Primary Outcome Measures :
  1. Sitting time [ Time Frame: Twelve weeks post-baseline ]
    Average hours of sitting time per day at work



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • From a local workplace in Victoria
  • Full-time employee (i.e., greater than 35 hours per week)
  • Reported over 5.5 hours of sitting per day at work
  • Agreed to attend the 3 intervention sessions

Exclusion Criteria:

  • Not from a local workplace in Victoria
  • Not a full-time employee (i.e., 35 hours or less per week)
  • Reported less than 5.5 hours of sitting per day at work
  • Did not agree to attend the 3 intervention sessions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04082624


Locations
Layout table for location information
Canada, British Columbia
Behavioural Medicine Laboratory
Victoria, British Columbia, Canada, V8P 5C2
Sponsors and Collaborators
University of Victoria
Social Sciences and Humanities Research Council of Canada
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ryan Rhodes, Primary investigator, University of Victoria
ClinicalTrials.gov Identifier: NCT04082624    
Other Study ID Numbers: 13-108
First Posted: September 9, 2019    Key Record Dates
Last Update Posted: September 9, 2019
Last Verified: September 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No